Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective

David M. G. Halpin*, Dave Singh, Ruth M. Hadfield

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

102 Citations (Scopus)
15 Downloads (Pure)

Abstract

There is no evidence on benefits or harms of inhaled steroids in COVID-19. It is essential that epidemiological studies of COVID-19 include detailed information on comorbidities and prior medication to help answer this question.
Original languageEnglish
Article numbere2001009
Pages (from-to)1-4
Number of pages4
JournalEuropean Respiratory Journal
Volume55
Issue number5
DOIs
Publication statusPublished - 1 May 2020

Bibliographical note

Copyright the Publisher 2020. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Fingerprint

Dive into the research topics of 'Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective'. Together they form a unique fingerprint.

Cite this